AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24565386 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 5 mL
Number of subjects: 75
Study 21533880 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore Seamguard (group A)
Number of subjects: 90
Study 21533880 — intervention group
Group type: COMPARATOR
Intervention: Continuous suture (group B)
Number of subjects: 90
Study 21162796 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% icodextrin (ICO)
Number of subjects: 54
Study 21162796 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 54
Study 17975182 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine
Number of subjects: 60
Study 17975182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 14996521 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 6
Study 14996521 — intervention group
Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 6
Study 12148861 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer displays with scene magnification initially set 5% higher than VOR gain, 10 sessions of 30 minutes twice daily for 5 days
Number of subjects: 9
Study 12148861 — intervention group
Group type: COMPARATOR
Intervention: Normal, x 1.0 magnification for each interaction session
Number of subjects: 9
Study 10434216 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg (C2)
Number of subjects: 61
Study 10434216 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.4 mg (C4)
Number of subjects: 61
Study 10434216 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (E) 300 micrograms.kg‐1 followed by a continuous infusion of 160 micrograms.kg‐1.min‐1
Number of subjects: 61
Study 10434216 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 61
Study 7822519 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene ointment 0.005%
Number of subjects: 277
Study 7822519 — intervention group
Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 277
Study 1709511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantogar
Number of subjects: 60
Study 1709511 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum‐2
Number of subjects: 60
Study 1709511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 597688 — intervention group
Group type: COMPARATOR
Intervention: Cohesive group discussion
Number of subjects: 51
Study 597688 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling and role‐rehearsal
Number of subjects: 51
Study 597688 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling and role‐rehearsal + daily social homework
Number of subjects: 51
Study 30905721 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT)
Number of subjects: 25
Study 30905721 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study 30905721 — intervention group
Group type: COMPARATOR
Intervention: Acute exercise (both groups)
Number of subjects: 25
Study 29231316 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation acupuncture
Number of subjects: 64
Study 29231316 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin (75 mg, twice a day)
Number of subjects: 64
Study 25312997 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention
Number of subjects: 862
Study 25312997 — intervention group
Group type: COMPARATOR
Intervention: Control group (AMC)
Number of subjects: 862
Study 25312997 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient factors (college education, private insurance, higher income, older age)
Number of subjects: 862
Study 25312997 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic type (FQHC vs AMC)
Number of subjects: 862
Study 23460328 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (WBVT) for 8 weeks starting from 1 month postoperatively
Number of subjects: 48
Study 23460328 — intervention group
Group type: COMPARATOR
Intervention: Conventional ACL rehabilitation
Number of subjects: 48
Study 21278620 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg IS-5-MN tablet
Number of subjects: 24
Study 21278620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19904666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 36
Study 19904666 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 36
Study 17026606 — intervention group
Group type: EXPERIMENTAL
Intervention: Proview Eye Pressure Monitor used three times daily for 30 days as an adjunct to the glaucoma regimen
Number of subjects: 32
Study 17026606 — intervention group
Group type: COMPARATOR
Intervention: Control group with no change in treatment regimen during the study phase
Number of subjects: 32
Study 14630841 — intervention group
Group type: EXPERIMENTAL
Intervention: Norian SRS cement
Number of subjects: 323
Study 14630841 — intervention group
Group type: COMPARATOR
Intervention: Control (cast or external fixator)
Number of subjects: 323
Study 12387697 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study 12387697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9727991 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (any)
Number of subjects: 2717
Study 9727991 — intervention group
Group type: COMPARATOR
Intervention: More expensive antibiotics
Number of subjects: 2717
Study 9727991 — intervention group
Group type: COMPARATOR
Intervention: Other antibiotics
Number of subjects: 2717
Study 9727991 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin and folate inhibitors
Number of subjects: 2717
Study 8172712 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium-89 (Metastron®)
Number of subjects: 28
Study 8172712 — intervention group
Group type: COMPARATOR
Intervention: Hormonal palliation
Number of subjects: 28
Study 8172712 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 28
Study 8172712 — intervention group
Group type: COMPARATOR
Intervention: Half-body irradiation
Number of subjects: 28
Study 2691885 — intervention group
Group type: COMPARATOR
Intervention: Hypoallergenic formula (semi-elementary formula Alfaré)
Number of subjects: 28
Study 2691885 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula adapted to human milk
Number of subjects: 28
Study 785177 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of sodium-aescinat administered intravenously for 3 days
Number of subjects: 18
Study 785177 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of aescinat administered for 6 days
Number of subjects: 18
Study 31850492 — intervention group
Group type: EXPERIMENTAL
Intervention: Priest-led intervention (short message about health during mass)
Number of subjects: 12
Study 31850492 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study 31014426 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive group sandplay
Number of subjects: 80
Study 31014426 — intervention group
Group type: COMPARATOR
Intervention: Individual sandplay
Number of subjects: 80
Study 28213610 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin consumption
Number of subjects: 0
Study 28213610 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 25456870 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 315
Study 25456870 — intervention group
Group type: COMPARATOR
Intervention: Phenprocoumon
Number of subjects: 315
Study 23520221 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity light therapy
Number of subjects: 101
Study 23520221 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity light therapy
Number of subjects: 101
Study 23520221 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 101
Study 21875638 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese live attenuated hepatitis A vaccine (H2 strain)
Number of subjects: 841
Study 21875638 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic inactivated hepatitis A vaccine (Healive(®))
Number of subjects: 841
Study 21875638 — intervention group
Group type: EXPERIMENTAL
Intervention: Imported inactivated hepatitis A vaccine (Havrix(®))
Number of subjects: 841
Study 21875638 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine (Control group)
Number of subjects: 841
Study 20141097 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatment options including pharmacotherapy, implantable cardioverter‐defibrillators, cardiac resynchronization therapy, and heart transplantation.
Number of subjects: 0
Study 20141097 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle changes such as restricting alcohol consumption, losing weight, exercising, quitting smoking, and eating a low‐sodium diet.
Number of subjects: 0
Study 16442458 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education programme using recreational methods and puppets
Number of subjects: 14
Study 16442458 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of puppets in therapeutic education
Number of subjects: 14
Study 16442458 — intervention group
Group type: EXPERIMENTAL
Intervention: Puppets' projective and transactional function
Number of subjects: 14
Study 15146229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing about someone else's cancer
Number of subjects: 244
Study 15146229 — intervention group
Group type: EXPERIMENTAL
Intervention: New aches and pains
Number of subjects: 244
Study 15146229 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 244
Study 15146229 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint stiffness
Number of subjects: 244
Study 15146229 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 244
Study 15146229 — intervention group
Group type: COMPARATOR
Intervention: Hearing about someone else's cancer (Caucasian women)
Number of subjects: 244
Study 15146229 — intervention group
Group type: COMPARATOR
Intervention: Environmental triggers (Caucasian women)
Number of subjects: 244
Study 15146229 — intervention group
Group type: COMPARATOR
Intervention: Information or controversy about breast cancer in media (Caucasian women)
Number of subjects: 244
Study 11717374 — intervention group
Group type: EXPERIMENTAL
Intervention: Protracted abstinence (12-17 months)
Number of subjects: 5
Study 11717374 — intervention group
Group type: COMPARATOR
Intervention: Short abstinence (<6 months)
Number of subjects: 5
Study 11717374 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological tests
Number of subjects: 5
Study 9812646 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Danshen Droplet Pills (CDDP)
Number of subjects: 64
Study 9812646 — intervention group
Group type: COMPARATOR
Intervention: Sordi
Number of subjects: 64
Study 9812646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 31976576 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral immunotherapy (OIT) with gradual increase to 53 mg/day for 1 year.
Number of subjects: 16
Study 31976576 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical control, avoided wheat).
Number of subjects: 16
Study 30355825 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser for enamel conditioning before pit and fissure sealant application
Number of subjects: 64
Study 30355825 — intervention group
Group type: COMPARATOR
Intervention: Routine application technique (control)
Number of subjects: 64
Study 27480813 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy intervention (CBTi) delivered by health-care assistants (HCAs) plus usual care
Number of subjects: 415
Study 27480813 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 415
Study 24161218 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding dysfunction assessment
Number of subjects: 56
Study 24161218 — intervention group
Group type: COMPARATOR
Intervention: Dysfunctional food manipulation
Number of subjects: 56
Study 24161218 — intervention group
Group type: COMPARATOR
Intervention: Mealtime aggression
Number of subjects: 56
Study 24161218 — intervention group
Group type: COMPARATOR
Intervention: Choking/gagging/vomiting
Number of subjects: 56
Study 24161218 — intervention group
Group type: COMPARATOR
Intervention: Resistance to eating
Number of subjects: 56
Study 24161218 — intervention group
Group type: COMPARATOR
Intervention: Parental aversion to mealtime
Number of subjects: 56
Study 24161218 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight z-scores
Number of subjects: 56
Study 24161218 — intervention group
Group type: EXPERIMENTAL
Intervention: Height z-scores
Number of subjects: 56
Study 24161218 — intervention group
Group type: EXPERIMENTAL
Intervention: Current gastrostomy tube use
Number of subjects: 56
Study 24161218 — intervention group
Group type: EXPERIMENTAL
Intervention: Single parent household
Number of subjects: 56
Study 22539845 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute dietary tryptophan depletion
Number of subjects: 0
Study 22539845 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 20003316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 2000 IU/day for 6 months
Number of subjects: 0
Study 20003316 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 0
Study 17314918 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 78
Study 17314918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 15289384 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress MR (DSMR)
Number of subjects: 79
Study 15289384 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress MR
Number of subjects: 79
Study 15289384 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress MR perfusion
Number of subjects: 79
Study 15289384 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress MR wall motion
Number of subjects: 79
Study 11176959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral thalamic deep brain stimulation (DBS)
Number of subjects: 21
Study 11176959 — intervention group
Group type: COMPARATOR
Intervention: Unilateral thalamic deep brain stimulation (DBS)
Number of subjects: 21
Study 9503735 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Held Health Record (PHR)
Number of subjects: 72
Study 9503735 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PHR)
Number of subjects: 72
Study 9503735 — intervention group
Group type: COMPARATOR
Intervention: Post test only group (no PHR)
Number of subjects: 72
Study 8066868 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml carbocaine 1%
Number of subjects: 57
Study 8066868 — intervention group
Group type: COMPARATOR
Intervention: 10 ml isotonic NaCl (control)
Number of subjects: 57
Study 3184334 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral clindamycin (150 mg/d)
Number of subjects: 22
Study 3184334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 4552431 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventolin (salbutamol)
Number of subjects: 16
Study 4552431 — intervention group
Group type: EXPERIMENTAL
Intervention: Medihaler‐Duo (isoprenaline/phenylephrine)
Number of subjects: 16
Study 4552431 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline (1/1,000) 0.5 ml
Number of subjects: 16
Study 4552431 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.6 mg
Number of subjects: 16
Study 4552431 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 16
Study 30770424 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically instrumented vitamin D levels (increase of 10 nmol/L)
Number of subjects: 313121
Study 30770424 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE ε4 allele presence (specifically ε4ε4 genotype)
Number of subjects: 313121
Study 28618158 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit and Facebook mHealth intervention
Number of subjects: 60
Study 28618158 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 60
Study 25240548 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 197
Study 25240548 — intervention group
Group type: COMPARATOR
Intervention: Control (uninflated cuff placed on upper arm for 40 min)
Number of subjects: 197
Study 22554345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (pRF)
Number of subjects: 22
Study 22554345 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injections
Number of subjects: 22
Study 22041889 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 20 mg once daily
Number of subjects: 800
Study 18811792 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive feeding educational programme (six sessions emphasizing child self‐feeding and maternal responsiveness)
Number of subjects: 100
Study 18811792 — intervention group
Group type: COMPARATOR
Intervention: Control group (sessions on foods to feed and nutritional disorders)
Number of subjects: 100
Study 18811792 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive feeding educational programme
Number of subjects: 100
Study 17234297 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring System (CGMS)
Number of subjects: 73
Study 17234297 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of plasma glucose (SM)
Number of subjects: 73
Study 15041584 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm steamed towel (at 45 degrees C) for 5 min
Number of subjects: 14
Study 11161416 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemination at the root's end (e.g., SMM)
Number of subjects: 0
Study 11161416 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of root-initial gemination
Number of subjects: 0
Study 10423595 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin (two 250 mg tablets)
Number of subjects: 18
Study 10423595 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two tablets)
Number of subjects: 18
Study 7957504 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g glucose load
Number of subjects: 10
Study 7957504 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g fat load
Number of subjects: 10
Study 7957504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertriglyceridaemic patients
Number of subjects: 10
Study 3300449 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 10
Study 3300449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31335759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket PATH (mobile health intervention)
Number of subjects: 105
Study 31335759 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study 31335759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket PATH
Number of subjects: 105
Study 31264958 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 718
Study 31264958 — intervention group
Group type: COMPARATOR
Intervention: Topical IOP-lowering eyedrops (Medicine-1st)
Number of subjects: 718
Study 28408714 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glucose exposure group
Number of subjects: 177
Study 28408714 — intervention group
Group type: COMPARATOR
Intervention: High-glucose exposure group
Number of subjects: 177
Study 28408714 — intervention group
Group type: EXPERIMENTAL
Intervention: High glucose exposure
Number of subjects: 177
Study 28408714 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted high glucose exposure
Number of subjects: 177
Study 28408714 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 177
Study 25740350 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR support application
Number of subjects: 84
Study 25740350 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 24517057 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 40
Study 24517057 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electric stimulation, only electrodes applied)
Number of subjects: 40
Study 22085713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballet classes
Number of subjects: 30
Study 22085713 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 30
Study 19843345 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made leather wrist splint (LS)
Number of subjects: 25
Study 19843345 — intervention group
Group type: COMPARATOR
Intervention: Commercially available fabric splint (FS)
Number of subjects: 25
Study 16704296 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 0
Study 16704296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15534055 — intervention group
Group type: EXPERIMENTAL
Intervention: High-education group (>6 years)
Number of subjects: 58
Study 15534055 — intervention group
Group type: COMPARATOR
Intervention: Low-education group (≤6 years)
Number of subjects: 58
Study 11523315 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg o.d.)
Number of subjects: 9
Study 11523315 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg o.d.)
Number of subjects: 9
Study 11523315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 9761083 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaspan alone (median dose 2,000 mg)
Number of subjects: 269
Study 9761083 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaspan plus a statin
Number of subjects: 269
Study 9761083 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaspan
Number of subjects: 269
Study 9761083 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaspan (combined with previous trials)
Number of subjects: 269
Study 7932969 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal sonography (TVS)
Number of subjects: 50
Study 7932969 — intervention group
Group type: COMPARATOR
Intervention: Endometrial biopsy
Number of subjects: 50
Study 3048364 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day non-residential exercise and living course
Number of subjects: 21